Inflammatory response to infectious pulmonary injury

被引:55
作者
Delclaux, C
Azoulay, E
机构
[1] Hop Henri Mondor, Serv Physiol Explorat Fonctionnelles, AP HP, F-94010 Creteil, France
[2] Univ Paris 12, INSERM, U492, Fac Med, Creteil, France
[3] Hop St Louis, Serv Reanimat Med, AP HP, Paris, France
关键词
alveolar macrophage; bacteria; cytokine; innate immunity; neutrophil; RESPIRATORY-DISTRESS SYNDROME; HOST-DEFENSE; BACTERIAL PNEUMONIA; INNATE IMMUNITY; PARTS; NEUTROPHILS; LUNG; PERMEABILITY; MACROPHAGES; IMMUNOLOGY;
D O I
10.1183/09031936.03.00420203
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
This review describing the inflammatory response to infectious pulmonary injury is focused on the innate immunity of the distal lung to bacterial pneumonia. The fact that the inflammatory response varies to some extent with the bacterial strain responsible for the infection is emphasised. The key cellular components present in the distal lung are described. The major role of alveolar macrophage is described, inasmuch as it responds to the usual daily challenges of bacteria entering the terminal airways and is capable of initiating an inflammatory reaction if the microbial challenge is either too large or too virulent. Under these conditions, the alveolar macrophages initiate an inflammatory response that recruits large numbers of neutrophils into the alveolar spaces. The strategy of the innate immune response may not be to recognise every possible antigen, but rather to focus on a few, highly conserved structures present in large groups of microorganisms. These structures are referred to as pathogen-associated molecular patterns and the receptors of the innate immune system that evolved to recognise them are called pattern-recognition receptors. The soluble factors in innate defence, such as cytokines, are described, and a last paragraph discusses whether a specific inflammatory response could characterise nosocomial pneumonia.
引用
收藏
页码:10S / 14S
页数:5
相关论文
共 29 条
[1]   Granulocyte colony-stimulating factor enhances host defenses against bacterial pneumonia following peritonitis in nonneutropenic rats [J].
Attalah, HL ;
Azoulay, E ;
Yang, K ;
Lasclos, C ;
Jouault, H ;
Soussy, CJ ;
Guillot, T ;
Brochard, L ;
Brun-Buisson, C ;
Harf, A ;
Delclaux, C .
CRITICAL CARE MEDICINE, 2002, 30 (09) :2107-2114
[2]   Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls [J].
Bauer, TT ;
Montón, C ;
Torres, A ;
Cabello, H ;
Fillela, X ;
Maldonado, A ;
Nicolás, JM ;
Zavala, E .
THORAX, 2000, 55 (01) :46-52
[3]   Nitric oxide and the immune response [J].
Bogdan, C .
NATURE IMMUNOLOGY, 2001, 2 (10) :907-916
[4]   Cytokine expression and release by neutrophils [J].
Cassatella, MA ;
Gasperini, S ;
Russo, MP .
PHAGOCYTES: BIOLOGY, PHYSIOLOGY, PATHOLOGY, AND PHARMACOTHERAPEUTICS, 1997, 832 :233-242
[5]  
Crestani B, 1998, KIDNEY INT, pS88
[6]   Surfactant proteins A and D and pulmonary host defense [J].
Crouch, E ;
Wright, JR .
ANNUAL REVIEW OF PHYSIOLOGY, 2001, 63 :521-554
[7]   COMPARTMENTALIZED CYTOKINE PRODUCTION WITHIN THE HUMAN LUNG IN UNILATERAL PNEUMONIA [J].
DEHOUX, MS ;
BOUTTEN, A ;
OSTINELLI, J ;
SETA, N ;
DOMBRET, MC ;
CRESTANI, B ;
DESCHENES, M ;
TROUILLET, JL ;
AUBIER, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (03) :710-716
[8]   The immune system - First of two parts [J].
Delves, PJ ;
Roitt, IM .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (01) :37-49
[9]   Advances in immunology: The immune system - Second of two parts. [J].
Delves, PJ ;
Roitt, IM .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (02) :108-117
[10]   Monocyte deactivation in septic patients: Restoration by IFN-gamma treatment [J].
Docke, WD ;
Randow, F ;
Syrbe, U ;
Krausch, D ;
Asadullah, K ;
Reinke, P ;
VolK, HD ;
Kox, W .
NATURE MEDICINE, 1997, 3 (06) :678-681